Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...
Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and access barriers stall outcomes Delays in care remain a critical issue. D’Avella ...
Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of U.S. medical oncologists. This is an ASCO Meeting Abstract from the ...
(MENAFN- EIN Presswire) EINPresswire/ -- "The chromosomal microarray reflex testing market is witnessing significant growth as advancements in genetic diagnostics continue to transform healthcare.
Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored This study of mutation testing in patients with NSCLC 25 and other studies that are measuring other genetic ...
Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s NGS ...
The state Department of Health is partnering with Diagnostic Laboratory Services and Clinical Laboratories of Ha-wai’i to encourage providers to do “reflex” hepatitis C testing, in hopes of screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results